查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930061

全球药物输送系统市场：市场规模、占有率、成长率、产业分析、类型、应用和地区因素及未来预测（2025-2034）

Drug Delivery Systems Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 143 Pages | 商品交期: 请询问到货日

价格

药物传输系统市场成长驱动因素

预计2025年全球药物输送系统市场规模将达到477.2亿美元，2026年将成长至493.5亿美元，最终在2034年达到705.2亿美元，预测期内复合年增长率（CAGR）为4.14%。北美将在2025年占市场主导地位，市场占有率为40.53%，主要驱动因素包括大规模新冠疫苗接种活动、住院人数增加以及对自我给药装置的强劲需求。预计到2032年，美国市场规模将达到252.2亿美元，主要驱动因素是家用和自我给药系统的普及。市场上的主要参与者，包括 BD（贝克顿·迪金森）、百特、格雷斯海默公司、美敦力、Nemera、Kindeva Drug Delivery、West Pharmaceutical Services 和 Ypsomed，都专注于创新、策略合作和产品拓展。

药物输送系统是一种旨在将药物输送到体内，并透过控制剂量、时间和释放部位来提高疗效和安全性的装置。该市场涵盖自动注射器、注射器、喷射注射器、吸入器和透皮给药系统，并透过医院药房、零售药房和线上管道进行分销。在新冠疫情期间，由于疫苗接种运动和对自我给药设备需求的增加，市场规模扩大，但由于最初医院准入限制，2020 年的增长暂时放缓。

市场驱动因素

慢性病日益增多：糖尿病、癌症、心血管疾病、气喘和慢性阻塞性肺病 (COPD) 等慢性病在全球范围内呈上升趋势，尤其是在老年人群中。根据联合健康基金会的报告，到 2022 年，美国将有 5,600 万 65 岁及以上的成年人面临慢性病风险，这将推动对高效、可控的药物输送系统的需求。

迈向先进药物输送系统：由于其精准性、标靶性和易用性，患者越来越倾向于使用先进的系统，尤其是自我给药设备。穿戴式平台、智慧胰岛素笔和整合式感测器的注射器等技术能够实现精确给药，减少全身副作用，并提高治疗效果。例如，2022 年 12 月，BioCorp 的 Maria 智慧感测器获得 FDA 批准，该感测器可将胰岛素笔转变为能够即时撷取资料的连网装置。

技术创新与策略合作：产品创新与合作是市场成长的支撑。值得关注的例子包括 Ypsomed 的 Ypsomate 自动注射器（2021 年）、Kindeva Drug Delivery 与 CHI 合作开发的干粉吸入器（2021 年）以及 Baxter 的 Novum IQ 注射帮浦（2022 年）。每家公司都致力于提升给药设备的便利性、安全性和数位化整合度。

市场限制因子

法规挑战与产品召回：严格的监管审批流程和产品召回可能会限制市场成长。例如，2022年10月，罗氏公司因性能问题召回了其Susvimo眼科给药装置；2021年6月，史密斯医疗公司因校准不准确召回了其胰岛素注射器。这些问题影响了产品的可靠性，并延缓了创新设备的上市。

市场区隔

按类型划分：注射剂市场将在2026年占主导地位，市场占有率达82.83%，这主要得益于全球疫苗接种计划的推进以及对可穿戴式註射器和注射器的需求不断增长。吸入剂市场也在成长，这主要得益于呼吸系统疾病的增加以及新型吸入器产品的上市。

按装置类型划分：传统装置市场将在2026年占78.33%的市场占有率，这主要得益于生物类似药和低成本装置的高普及率，尤其是在发展中国家。先进装置市场预计将成长最快，这主要得益于患者依从性的提高、标靶给药以及技术的进步。

按分销管道划分：受就诊量增加和基础设施建设的推动，医院药房将在2026年占63.77%的市场占有率。零售药局和线上/居家医疗保健管道也因其便利性和可近性而呈现成长态势。

区域展望

  • 北美：预计2025年市场规模将达193.4亿美元，2026年将达188.7亿美元。成长主要得益于疫苗接种运动、住院人数增加以及自我给药系统的广泛应用。
  • 欧洲：预计将显着成长，其中英国预计在2026年将达到20.7亿美元，德国预计将达到36.9亿美元。这一增长主要得益于公众意识的提高、临床试验的发展、新产品的上市。
  • 亚太地区：成长最快的地区。 预计2026年，日本的医疗支出将达到28.2亿美元，中国将达到33.2亿美元，印度将达到8.1亿美元。成长的驱动因素包括人口规模、慢性病盛行率以及製造业基地的扩张。 拉丁美洲、中东和非洲：由于医疗保健支出增加、住院人数上升以及人们对慢性病管理的认识提高，预计这些地区的医疗支出将保持温和增长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 药物传​​输系统的技术进步
  • 新产品发布
  • 主要产业发展－併购与合作
  • 新冠疫情对全球药物输送系统市场的影响

第五章 全球药物传输系统市场分析：洞察与预测 （2021-2034）

  • 市场分析、洞察与预测：依类型划分
    • 吸入
    • 透皮
    • 注射
    • 其他
  • 市场分析、洞察与预测：依设备类型划分
    • 传统设备
    • 先进设备
  • 市场分析、洞察与预测：依通路划分
    • 医院药房
    • 零售药房
    • 其他
  • 市场分析、洞察与预测：按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美药物传输系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲药物输送系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 德国
    • 其他欧洲国家

第八章 亚太地区药物传递系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 东南亚
    • 其他地区亚太地区

第九章：拉丁美洲药物输送系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲药物输送系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会
    • 南非
    • 中东和非洲其他地区

第十一章：竞争分析

  • 全球市占率分析（2025）
  • 公司简介
    • Gerresheimer股份公司
    • BD
    • Kindeva 药物输送
    • 巴克斯特
    • West Pharmaceutical Services Inc.
    • 伊普索梅德
    • 美敦力
    • 内马拉
    • E3D Elcam 药物输送装置
Product Code: FBI103070

Growth Factors of drug delivery systems Market

The global drug delivery systems market was valued at USD 47.72 billion in 2025 and is projected to grow to USD 49.35 billion in 2026, ultimately reaching USD 70.52 billion by 2034, representing a CAGR of 4.14% during the forecast period. North America dominated the market in 2025 with a 40.53% share, driven by mass COVID-19 vaccination campaigns, increasing hospital admissions, and a strong preference for self-administered drug delivery devices. The U.S. market is expected to reach USD 25.22 billion by 2032, driven by the shift toward home-use and self-administered systems. Key players include BD (Becton Dickinson), Baxter, Gerresheimer AG, Medtronic, Nemera, Kindeva Drug Delivery, West Pharmaceutical Services Inc., and Ypsomed, focusing on innovation, strategic collaborations, and product expansion.

Drug delivery systems are devices designed to introduce drugs into the body while improving efficacy and safety by controlling dosage, timing, and site of release. The market encompasses auto-injectors, syringes, jet injectors, inhalers, and transdermal systems, which are distributed through hospital pharmacies, retail pharmacies, and online channels. The market witnessed a boost during the COVID-19 pandemic due to vaccination drives and increased demand for self-administered devices, although initial hospital access restrictions temporarily slowed growth in 2020.

Market Drivers

Rising Chronic Disease Prevalence: Chronic diseases, including diabetes, cancer, cardiovascular disorders, asthma, and COPD, have been increasing globally, especially among the geriatric population. According to the United Health Foundation, in 2022, 56 million U.S. adults aged 65 and above are susceptible to chronic diseases, boosting the demand for efficient and controlled drug delivery systems.

Shift Toward Advanced Drug Delivery Systems: Patients increasingly prefer advanced systems for their accuracy, targeted delivery, and user-friendliness, particularly self-administered devices. Technologies like on-body platforms, smart insulin pens, and sensor-embedded injectors provide precise dosing, reduce systemic side effects, and enhance therapeutic outcomes. For example, in December 2022, Biocorp received FDA approval for Mallya, a smart sensor that converts insulin pens into connected devices for real-time data collection.

Technological Innovations and Strategic Collaborations: Market growth is supported by product innovations and collaborations. Notable examples include Ypsomed's YpsoMate auto-injector (2021), KINDEVA DRUG DELIVERY's collaboration with CHI for a dry powder inhaler (2021), and Baxter's Novum IQ syringe infusion pump (2022). Companies are focusing on improving convenience, safety, and digital integration of drug delivery devices.

Market Restraints

Regulatory Challenges and Product Recalls: Strict regulatory approval processes and product recalls can limit growth. For instance, in October 2022, Roche recalled the Susvimo eye drug delivery device due to performance issues, and in June 2021, Smiths Medical recalled insulin syringes due to inaccurate markings. Such issues impact trust and slow the introduction of innovative devices.

Market Segmentation

By Type: The injectable segment dominated in 2026 with an 82.83% share, fueled by global vaccination drives, wearable injectors, and rising syringe demand. The inhalation segment is also growing, driven by increasing respiratory disorders and new inhaler product launches.

By Device Type: The conventional segment held a 78.33% share in 2026, attributed to the high adoption of biosimilars and low-cost devices, especially in developing countries. The advanced segment is expected to grow fastest due to enhanced patient compliance, targeted delivery, and technological advancements.

By Distribution Channel: Hospital pharmacies dominate with 63.77% share in 2026, driven by increased hospital visits and infrastructure. Retail pharmacies and online/homecare channels are experiencing growth due to accessibility and convenience.

Regional Insights

  • North America: USD 19.34 billion in 2025; projected USD 18.87 billion in 2026. Growth driven by vaccination campaigns, hospital admissions, and adoption of self-administered systems.
  • Europe: Significant growth, with the UK projected at USD 2.07 billion and Germany at USD 3.69 billion in 2026, supported by awareness, clinical trials, and new product launches.
  • Asia Pacific: Fastest-growing region; Japan USD 2.82 billion, China USD 3.32 billion, and India USD 0.81 billion in 2026, driven by population size, chronic disease prevalence, and expanding manufacturing.
  • Latin America & Middle East & Africa: Moderate growth due to increasing healthcare expenditure, hospital admissions, and rising awareness of chronic disease management.

Competitive Landscape

The market is fragmented, with major players like BD, Baxter, Gerresheimer AG, West Pharmaceutical Services Inc., Medtronic, Nemera, Kindeva Drug Delivery, and Ypsomed focusing on product launches, geographical expansion, and manufacturing capacity enhancement. Examples include Nemera's new facility in Poland (2023) and BD Effivax prefillable vaccine syringes (2022).

Conclusion

The global drug delivery systems market is expected to grow from USD 47.72 billion in 2025 to USD 70.52 billion by 2034, driven by rising chronic disease prevalence, increasing patient preference for advanced and self-administered devices, technological innovations, and strategic collaborations. North America leads the market, while Asia Pacific offers the fastest growth. Injectable devices dominate, supported by global vaccination and chronic disease management efforts, whereas advanced drug delivery technologies provide enhanced therapeutic outcomes. Strategic product development, digital integration, and expanding manufacturing capabilities will continue to propel market growth, ensuring better patient compliance and global adoption of innovative drug delivery solutions.

Segmentation By Type

  • Inhalation
  • Transdermal
  • Injectable
  • Others

By Device Type

  • Conventional
  • Advanced

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Region

  • North America (By Type, Device Type, Distribution Channel, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Device Type, Distribution Channel, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Device Type, Distribution Channel, and Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Device Type, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Device Type, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Drug Delivery Systems
  • 4.2. New Product Launches
  • 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.4. Impact of COVID-19 on Global Drug Delivery Systems Market

5. Global Drug Delivery Systems Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Inhalation
    • 5.1.2. Transdermal
    • 5.1.3. Injectable
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Device Type
    • 5.2.1. Conventional
    • 5.2.2. Advanced
  • 5.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.3.1. Hospital Pharmacies
    • 5.3.2. Retail Pharmacies
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Drug Delivery Systems Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Inhalation
    • 6.1.2. Transdermal
    • 6.1.3. Injectable
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Device Type
    • 6.2.1. Conventional
    • 6.2.2. Advanced
  • 6.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.3.1. Hospital Pharmacies
    • 6.3.2. Retail Pharmacies
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Drug Delivery Systems Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Inhalation
    • 7.1.2. Transdermal
    • 7.1.3. Injectable
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Device Type
    • 7.2.1. Conventional
    • 7.2.2. Advanced
  • 7.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. France
    • 7.4.2. Italy
    • 7.4.3. Spain
    • 7.4.4. U.K.
    • 7.4.5. Germany
    • 7.4.6. Rest of Europe

8. Asia Pacific Drug Delivery Systems Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Inhalation
    • 8.1.2. Transdermal
    • 8.1.3. Injectable
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Device Type
    • 8.2.1. Conventional
    • 8.2.2. Advanced
  • 8.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Drug Delivery Systems Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Inhalation
    • 9.1.2. Transdermal
    • 9.1.3. Injectable
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Device Type
    • 9.2.1. Conventional
    • 9.2.2. Advanced
  • 9.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Drug Delivery Systems Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Inhalation
    • 10.1.2. Transdermal
    • 10.1.3. Injectable
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Device Type
    • 10.2.1. Conventional
    • 10.2.2. Advanced
  • 10.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis ( 2025)
  • 11.2. Company Profiles
    • 11.2.1. Gerresheimer AG
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. BD
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Kindeva Drug Delivery
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Baxter
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. West Pharmaceutical Services Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Ypsomed
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Medtronic
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Nemara
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. E3D Elcam Drug Delivery Devices
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Drug Delivery Systems Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Drug Delivery Systems Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 3: Global Drug Delivery Systems Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 4: Global Drug Delivery Systems Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Drug Delivery Systems Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 6: North America Drug Delivery Systems Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 7: North America Drug Delivery Systems Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 8: North America Drug Delivery Systems Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Drug Delivery Systems Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 10: Europe Drug Delivery Systems Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 11: Europe Drug Delivery Systems Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 12: Europe Drug Delivery Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Drug Delivery Systems Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Asia Pacific Drug Delivery Systems Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 15: Asia Pacific Drug Delivery Systems Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 16: Asia Pacific Drug Delivery Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Drug Delivery Systems Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 18: Latin America Drug Delivery Systems Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 19: Latin America Drug Delivery Systems Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 20: Latin America Drug Delivery Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Drug Delivery Systems Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 22: Middle East & Africa Drug Delivery Systems Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 23: Middle East & Africa Drug Delivery Systems Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 24: Middle East & Africa Drug Delivery Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Drug Delivery Systems Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Drug Delivery Systems Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Drug Delivery Systems Market Value Share (%), by Device Type, 2025 & 2034
  • Figure 4: Global Drug Delivery Systems Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 5: Global Drug Delivery Systems Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Drug Delivery Systems Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Drug Delivery Systems Market Value Share (%), by Type, 2025
  • Figure 8: North America Drug Delivery Systems Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 9: North America Drug Delivery Systems Market Value Share (%), by Device Type, 2025
  • Figure 10: North America Drug Delivery Systems Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 11: North America Drug Delivery Systems Market Value Share (%), by Distribution Channel, 2025
  • Figure 12: North America Drug Delivery Systems Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Drug Delivery Systems Market Value Share (%), By Country, 2025
  • Figure 14: Europe Drug Delivery Systems Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Drug Delivery Systems Market Value Share (%), by Type, 2025
  • Figure 16: Europe Drug Delivery Systems Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 17: Europe Drug Delivery Systems Market Value Share (%), by Device Type, 2025
  • Figure 18: Europe Drug Delivery Systems Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 19: Europe Drug Delivery Systems Market Value Share (%), by Distribution Channel, 2025
  • Figure 20: Europe Drug Delivery Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Drug Delivery Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Drug Delivery Systems Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Drug Delivery Systems Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Drug Delivery Systems Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 25: Asia Pacific Drug Delivery Systems Market Value Share (%), by Device Type, 2025
  • Figure 26: Asia Pacific Drug Delivery Systems Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 27: Asia Pacific Drug Delivery Systems Market Value Share (%), by Distribution Channel, 2025
  • Figure 28: Asia Pacific Drug Delivery Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Drug Delivery Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Drug Delivery Systems Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Drug Delivery Systems Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Drug Delivery Systems Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 33: Latin America Drug Delivery Systems Market Value Share (%), by Device Type, 2025
  • Figure 34: Latin America Drug Delivery Systems Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 35: Latin America Drug Delivery Systems Market Value Share (%), by Distribution Channel, 2025
  • Figure 36: Latin America Drug Delivery Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Drug Delivery Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Drug Delivery Systems Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Drug Delivery Systems Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Drug Delivery Systems Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 41: Middle East & Africa Drug Delivery Systems Market Value Share (%), by Device Type, 2025
  • Figure 42: Middle East & Africa Drug Delivery Systems Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 43: Middle East & Africa Drug Delivery Systems Market Value Share (%), by Distribution Channel, 2025
  • Figure 44: Middle East & Africa Drug Delivery Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Drug Delivery Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Drug Delivery Systems Market Share (%), By Company, 2025